Albanese C T, Smith S D, Watkins S, Kurkchubasche A, Simmons R L, Rowe M I
Department of Pediatric Surgery, Children's Hospital of Pittsburgh, PA.
J Am Coll Surg. 1994 Dec;179(6):679-88.
Bacterial translocation is a process believed to result in nosocomial infections. Secretory IgA (sIgA) may have a role in the prevention of translocation by its ability to bind and aggregate bacteria, a function termed "immune exclusion." The present study was done to determine the effect of specific binding of sIgA to bacteria on the movement of these organisms across the intact epithelial membrane.
Bacterial translocation across intact intestinal segments of rats were assessed in vitro using the Ussing model. Secretory IgA (0.25 mg per mL) from pooled human colostrum was added to the perfused segments of ileum in the Ussing system. Subsequently, the membranes were exposed to 5 x 10(9) cfu per mL Escherichia coli on their mucosal side. A second experiment tested the effect of human IgG when perfused with E. coli using the same preparation. All experiments had paired matched rats in a control group without immunoglobulin. The ability of sIgA and IgG to bind to E. coli was studied by an in vitro assay, as well as by transmission electron microscopy and immunofluorescence of random IgA/E. coli experiments. Measurements obtained in all experimental and control groups were the incidence and amount of bacterial passage and the potential difference generated by the intestinal segments (an index of viability).
There were no differences in potential difference between control and experimental groups in either of the two experiments. Secretory IgA bound E. coli and completely prevented passage of E. coli as compared with rats in the control group. IgG bound E. coli; however, the incidence of passage was equal to that of rats in the control group. However, the presence of IgG resulted in a significantly reduced number of bacteria that passed when compared with controls (p < 0.05). Electron microscopic studies revealed intact surface morphology and immunofluorescence revealed aggregates of IgA and E. coli on the mucosal, but not submucosal, surface of the ileal membranes.
This study provides direct evidence of immune exclusion by sIgA. When bound to bacteria, it prevents passage across a morphologically intact segment of viable intestinal tissue.
细菌移位是一个被认为会导致医院感染的过程。分泌型免疫球蛋白A(sIgA)可能因其结合和聚集细菌的能力(一种称为“免疫排斥”的功能)而在预防细菌移位方面发挥作用。本研究旨在确定sIgA与细菌的特异性结合对这些微生物穿过完整上皮膜的运动的影响。
使用Ussing模型在体外评估细菌穿过大鼠完整肠段的移位情况。将来自人初乳池的分泌型免疫球蛋白A(0.25毫克/毫升)添加到Ussing系统中回肠的灌注段。随后,将膜在其黏膜侧暴露于每毫升5×10⁹ 菌落形成单位的大肠杆菌。第二个实验使用相同制剂在灌注大肠杆菌时测试人免疫球蛋白G的作用。所有实验在无免疫球蛋白的对照组中均有配对的匹配大鼠。通过体外试验以及透射电子显微镜和随机IgA/大肠杆菌实验的免疫荧光研究sIgA和免疫球蛋白G与大肠杆菌结合的能力。在所有实验组和对照组中获得的测量值包括细菌通过的发生率和数量以及肠段产生的电位差(活力指标)。
在两个实验中的任何一个中,对照组和实验组之间的电位差均无差异。与对照组大鼠相比,分泌型免疫球蛋白A结合大肠杆菌并完全阻止了大肠杆菌的通过。免疫球蛋白G结合大肠杆菌;然而,通过的发生率与对照组大鼠相同。然而,与对照组相比,免疫球蛋白G的存在导致通过的细菌数量显著减少(p<0.05)。电子显微镜研究显示表面形态完整,免疫荧光显示在回肠膜的黏膜而非黏膜下表面有IgA和大肠杆菌的聚集体。
本研究提供了sIgA免疫排斥的直接证据。当与细菌结合时,它可防止细菌穿过形态完整的存活肠组织段。